Evidence map›Paper›PMID 39159052›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2024

Ultrasmall Nanodots with Dual Anti-Ferropototic Effect for Acute Kidney Injury Therapy.

Fantian Zeng, Yatong Qin, Sureya Nijiati, Yangtengyu Liu, Jinmin Ye, Huaxiang Shen, Jiayuan Cai, Hehe Xiong, Changrong Shi, Longguang Tang and 2 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Ultrasmall Nanodots with Dual Anti-Ferropototic Effect for Acute Kidney Injury Therapy.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Fantian ZengState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Yatong QinState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Sureya NijiatiState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Yangtengyu LiuDepartment of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, 410008, China.
Jinmin YeState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Huaxiang ShenState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Jiayuan CaiState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Hehe XiongState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Changrong ShiState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.
Longguang TangGaozhou People's Hospital, Maoming, 525200, China.
Chunyang YuSchool of Chemistry and Chemical Engineering, State Key Laboratory of Metal Matrix Composites, Shanghai Jiao Tong University, 800 Dongchuan Road, Shanghai, 200240, China.
Zijian ZhouState Key Laboratory of Vaccines for Infectious Diseases, Xiang An Biomedicine Laboratory, School of Public Health, Shenzhen Research Institute of Xiamen University, Xiamen University, Xiamen, 361102, China.ORCID 0000-0003-2383-8490

Funding

China Postdoctoral Science Foundation 2022M722654National Natural Science Foundation of China 32201127National Natural Science Foundation of China 82270113National Natural Science Foundation of China 82272136National Natural Science Foundation of China 82302052National Natural Science Foundation of China 82302358Natural Science Foundation of Fujian Province of China 2023J06007Natural Science Foundation of Guangdong Province 2023A1515011386postdoctoral innovation talents support program BX20230200Shenzhen Science and Innovation Committee JCYJ20220530143400001
6 · The paper itself

Abstract

Ferroptosis is known to mediate the pathogenesis of chemotherapeutic drug-induced acute kidney injury (AKI); however, leveraging the benefits of ferroptosis-based treatments for nephroprotection remains challenging. Here, ultrasmall nanodots, denoted as FerroD, comprising the amphiphilic conjugate (tetraphenylethylene-

Indexed as

Acute Kidney InjuryDisease Models, AnimalFerroptosisAnimalsCisplatinCyclohexylaminesDeferoxamineMaleMiceNanoparticlesPhenylenediaminesCisplatinCyclohexylaminesDeferoxamineferrostatin-1Phenylenediaminesacute kidney injuryferroptosisnanodots

Identifiers

PMID39159052
PMCPMC11497046

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.